Valentin Navarro-Pérez

Learn More
BACKGROUND A major problem in cancer chemotherapy is the existence of primary resistance and/or the acquisition of secondary resistance. Many cellular defects contribute to chemoresistance, but epigenetic changes can also be a cause. METHODS A DNA methylation microarray was used to identify epigenetic differences in oxaliplatin-sensitive and -resistant(More)
  • 1